digitalstudios2024-11-19T11:57:34+00:00Enterprise Therapeutics Publishes on Medicinal Chemistry of ETD001 | A Novel Inhaled ENaC Blocker for Treatment of Cystic Fibrosis
digitalstudios2024-11-19T11:53:44+00:00Cytomos Secures £5M | To Scale Up Production of Cell-analysis Technology